1. L. Birnbaum, Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus, Drug Metab. Dispos.
14, 34–40 (1986).
2. T. A. Gasiewicz and G. Rucci, Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for a homologous nature among mammalian species, Mol. Pharmacol.
26, 90–98 (1984).
3. R. Pohjanvirta, T. Vartiainen, A. Uusirauva, J. Monkkonen, and J. Tuomisto, Tissue distribution, metabolism, and excretion of [14C]-TCDD in a TCDD-susceptible and a TCDD-resistant rat strain, Pharmacol. Toxicol.
66, 93–100 (1990).
4. J. Q. Rose, J. C. Ramsey, T. H. Wentzler, R. A. Hummel, and P. J. Gehring, The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat, Toxicol. Appl. Pharmacol.
36, 209–226 (1976).
5. H. Poiger and C. Schlatter, Pharmacokinetics of 2,3,7,8-TCDD in man, Chemosphere
15, 1489–1494 (1986).